Company Performance - Dave & Buster's reported quarterly earnings of $0.76 per share, missing the Zacks Consensus Estimate of $0.96 per share, and down from $1.12 per share a year ago, representing an earnings surprise of -20.83% [1][2] - The company posted revenues of $567.7 million for the quarter, surpassing the Zacks Consensus Estimate by 0.74%, but down from $588.1 million year-over-year [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.81 on revenues of $549.08 million, and for the current fiscal year, it is $1.69 on revenues of $2.14 billion [8] - The estimate revisions trend for Dave & Buster's is currently unfavorable, resulting in a Zacks Rank 5 (Strong Sell), indicating expected underperformance in the near future [7] Industry Context - The Retail - Restaurants industry, to which Dave & Buster's belongs, is currently in the bottom 25% of over 250 Zacks industries, suggesting that the outlook for the industry can significantly impact stock performance [9] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [6]

Financial Performance - Core & Main reported quarterly earnings of $0.52 per share, matching the Zacks Consensus Estimate, and an increase from $0.49 per share a year ago [1] - The company posted revenues of $1.91 billion for the quarter ended April 2025, exceeding the Zacks Consensus Estimate by 4.29%, compared to $1.74 billion in the same quarter last year [2] - Over the last four quarters, Core & Main has surpassed consensus revenue estimates three times [2] Stock Performance - Core & Main shares have increased approximately 16.5% since the beginning of the year, significantly outperforming the S&P 500's gain of 2.1% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.75 on revenues of $2.11 billion, and for the current fiscal year, it is $2.43 on revenues of $7.71 billion [7] - The trend of estimate revisions for Core & Main is mixed, which may change following the recent earnings report [6] Industry Context - Core & Main operates within the Manufacturing - Tools & Related Products industry, which is currently ranked in the bottom 11% of over 250 Zacks industries [8] - Historical data indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1 [8]

Hims & Hers Health, Inc. (HIMS) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.The upward trend in estimate revisions for this company reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends ...

Core Insights - ABM Industries reported quarterly earnings of $0.86 per share, missing the Zacks Consensus Estimate of $0.87 per share, and down from $0.87 per share a year ago [1] - The company posted revenues of $2.11 billion for the quarter, exceeding the Zacks Consensus Estimate by 2.24% and up from $2.02 billion year-over-year [3] Earnings Performance - The earnings surprise for the quarter was -1.15%, while the previous quarter saw an earnings surprise of 11.54% [2] - Over the last four quarters, ABM Industries has surpassed consensus EPS estimates three times [2] Revenue Performance - ABM Industries has topped consensus revenue estimates four times over the last four quarters [3] Stock Performance - Since the beginning of the year, ABM Industries shares have increased by about 0.2%, compared to a 1% gain in the S&P 500 [4] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.97 on revenues of $2.16 billion, and for the current fiscal year, it is $3.76 on revenues of $8.58 billion [8] - The estimate revisions trend for ABM Industries is currently favorable, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [7] Industry Context - The Business - Services industry, to which ABM Industries belongs, is currently in the top 15% of over 250 Zacks industries, suggesting a positive outlook for stocks in this sector [9]

Petco Health & Wellness (WOOF) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 50%. A quarter ago, it was expected that this pet store chain would post earnings of $0.02 per share when it actually produced break-even earnings, delivering a surprise of -100%.Over the last four quarters, the co ...

Company Performance - Lululemon reported quarterly earnings of $2.60 per share, exceeding the Zacks Consensus Estimate of $2.59 per share, and showing an increase from $2.54 per share a year ago, representing an earnings surprise of 0.39% [1] - The company posted revenues of $2.37 billion for the quarter ended April 2025, surpassing the Zacks Consensus Estimate by 0.59%, and up from $2.21 billion year-over-year [2] - Over the last four quarters, Lululemon has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Stock Outlook - Lululemon shares have declined approximately 12.4% since the beginning of the year, while the S&P 500 has gained 1.5% [3] - The current consensus EPS estimate for the upcoming quarter is $3.27 on revenues of $2.56 billion, and for the current fiscal year, it is $14.72 on revenues of $11.19 billion [7] Industry Context - The Textile - Apparel industry, to which Lululemon belongs, is currently ranked in the bottom 28% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Lululemon's stock performance [5]

Core Viewpoint - Verb Technology Company, Inc. (VERB) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][2]. Earnings Estimates and Stock Price Impact - The Zacks rating system is effective for individual investors as it focuses on earnings estimate revisions, which are strongly correlated with near-term stock price movements [2][3]. - Institutional investors rely on earnings estimates to determine the fair value of stocks, leading to significant buying or selling activity that affects stock prices [3]. Company Performance Indicators - Verb Technology's rising earnings estimates and the Zacks rating upgrade suggest an improvement in the company's underlying business, which is expected to drive the stock price higher [4]. - For the fiscal year ending December 2025, Verb Technology is projected to earn -$8.03 per share, reflecting a 58.8% change from the previous year [7]. Zacks Rank System Overview - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [6]. - Verb Technology's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [9].

Group 1: Earnings Performance - HealthEquity reported quarterly earnings of $0.97 per share, exceeding the Zacks Consensus Estimate of $0.81 per share, and up from $0.80 per share a year ago [1] - The earnings surprise for this quarter was 19.75%, while the previous quarter had a surprise of -2.82% with actual earnings of $0.69 compared to an expectation of $0.71 [2] - Over the last four quarters, HealthEquity has surpassed consensus EPS estimates three times [2] Group 2: Revenue Performance - The company posted revenues of $330.84 million for the quarter ended April 2025, surpassing the Zacks Consensus Estimate by 3.03%, and up from $287.6 million year-over-year [3] - HealthEquity has topped consensus revenue estimates four times over the last four quarters [3] Group 3: Stock Performance and Outlook - HealthEquity shares have increased by approximately 7.2% since the beginning of the year, compared to a 0.9% gain in the S&P 500 [4] - The current consensus EPS estimate for the upcoming quarter is $0.88 on revenues of $319.33 million, and for the current fiscal year, it is $3.60 on $1.3 billion in revenues [8] Group 4: Industry Context - The Medical Services industry, to which HealthEquity belongs, is currently ranked in the top 28% of over 250 Zacks industries, indicating a favorable outlook [9] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [6]

Signet (SIG) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1.11 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 16.83%. A quarter ago, it was expected that this jewelry company would post earnings of $6.39 per share when it actually produced earnings of $6.62, delivering a surprise of 3.60%.Over the last four quarters, the company has ...

Company Performance - Marvell Technology reported quarterly earnings of $0.62 per share, exceeding the Zacks Consensus Estimate of $0.61 per share, and showing significant growth from $0.24 per share a year ago, representing an earnings surprise of 1.64% [1] - The company achieved revenues of $1.9 billion for the quarter ended April 2025, surpassing the Zacks Consensus Estimate by 1.04%, and up from $1.16 billion in the same quarter last year [2] - Over the last four quarters, Marvell has consistently surpassed consensus EPS and revenue estimates [2] Stock Outlook - Marvell shares have declined approximately 41.5% since the beginning of the year, contrasting with the S&P 500's slight gain of 0.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.65 on revenues of $1.98 billion, and for the current fiscal year, it is $2.75 on revenues of $8.28 billion [7] - The estimate revisions trend for Marvell is currently unfavorable, resulting in a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [6] Industry Context - The Electronics - Semiconductors industry, to which Marvell belongs, is currently ranked in the bottom 48% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Marvell's stock performance [5]